Atlas FDA

TRILURON

FDA premarket approval P180040 · decided 2019-03-26

Approval details

PMA number
P180040
Trade name
TRILURON
Generic name
Acid, hyaluronic, intraarticular
Applicant
Fidia Farmaceutici S.P.A.
Date received
2018-09-27
Decision date
2019-03-26
Days to decision
180 days
Decision code
APPR
Product code
MOZ
Advisory committee
Orthopedic
Expedited review
No
Location
Abano Terme
Statement
Approval for TRILURON. The device is indicated for use in the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics (e.g., acetaminophen).

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
HyaloGYN Vaginal Moisturizing Suppositories (K191052)Fidia Farmaceutici S.P.A.2020-01-09
HyaloGYN Vaginal Hydrating Gel (K150883)Fidia Farmaceutici S.P.A.2015-09-01
HYALO GYN (K094039)Fidia Farmaceutici S.P.A.2010-05-07